Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

December 24, 2002; 59 (12) Brief Communications

[123I]-FP-CIT-SPECT in the early diagnosis of PD presenting as exercise-induced dystonia

Regina Katzenschlager, Durval Costa, Svetislav Gacinovic, Andrew J. Lees
First published December 24, 2002, DOI: https://doi.org/10.1212/01.WNL.0000037484.28297.66
Regina Katzenschlager
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Durval Costa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Svetislav Gacinovic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew J. Lees
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
[123I]-FP-CIT-SPECT in the early diagnosis of PD presenting as exercise-induced dystonia
Regina Katzenschlager, Durval Costa, Svetislav Gacinovic, Andrew J. Lees
Neurology Dec 2002, 59 (12) 1974-1976; DOI: 10.1212/01.WNL.0000037484.28297.66

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
441

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

Isolated foot dystonia following exercise is a rare manifestation of early PD. It may precede the onset of parkinsonism by years and can be clinically indistinguishable from familial exercise-induced dystonia. The authors present a patient with dystonic claudication where dopamine transporter SPECT using 123I-FP-CIT allowed early diagnosis of PD and enabled effective symptomatic treatment with a dopamine agonist.

Dystonic foot cramps as the presenting symptom of PD were first described in 1898.1 Their restricted appearance only after leg exercise was described later2 and the term dystonic claudication was proposed. Intermittent painful leg cramps on exercise can have a variety of underlying causes. In the absence of other physical signs that might suggest lumbar canal or peripheral vascular disease, the main differential diagnoses are familial paroxysmal exercise-induced dystonia and early PD. Early differentiation between these conditions is important because they differ with respect to prognosis and treatment.

We report a patient with isolated exercise-induced unilateral leg dystonia where SPECT using [123I]-2β-carbomethoxy-3β-(-4-iodophenyl)-N-(3-fluoropropyl)-nortropane (123I-FP-CIT) indicated nigrostriatal dopaminergic degeneration and facilitated the early diagnosis of PD.

123I-FP-CIT is a new SPECT ligand that binds with high specific affinity to presynaptic dopamine transporters. SPECT results obtained with 123I-FP-CIT have been shown to match those found with the ligand 123I-β-CIT in healthy volunteers and in patients with PD.3 Whereas 123I-β-CIT reaches an equilibrium after about 24 hours, the faster kinetics of 123I-FP-CIT allow for scanning within 3 to 6 hours after administration.

Case report.

A 43-year-old man who had been previously well and kept a regular exercise regime noticed recurrent painful cramps in his left foot when exercising in the gymnasium. These consistently occurred after 5 minutes on the treadmill and 15 minutes on the exercise bicycle. On stopping the exercise, the cramps subsided within less than a minute. There was no family history of neurologic disease.

Five months earlier, the patient had presented to an orthopedic surgeon with pain in his left shoulder, which was precipitated by movement. MRI showed mild narrowing of the acromioclavicular distance and mild supraspinatus tendonitis, considered to be in keeping with a clinical diagnosis of rotator cuff tendonitis. Anti-inflammatory drugs and physiotherapy were of some help.

He went back to the orthopedic surgeon when the foot cramps developed. Spinal canal stenosis was suspected but results of MRI of the lumbar spine and EMG were normal.

The patient was referred for a neurologic opinion. On neurologic examination, no abnormalities were found, and the patient was asked to provide a home video depicting his difficulties. This revealed clawing of the toes and dorsiflexion of the left big toe after exercise. MRI of the brain had normal results. SPECT was performed on a GE XCT single detector gamma camera/STAR computer system (GE, Milwaukee, WI) fitted with a high-resolution parallel hole collimator, 3.5 hours after IV injection of 123I-P-CIT (185 MBq). Total striatal binding potential index (BP%) was obtained using the following formula: [(BG − Bk)/Bk] × 100 for each hemisphere (right and left), where basal ganglia uptake (BG) = specific + nonspecific binding, and nonspecific binding = background (Bk) = occipital cortex. SPECT showed bilateral and asymmetric reduction of striatal tracer uptake, thus confirming a presynaptic dopaminergic deficit (figure 1). Total striatal BP% compared to nonspecific uptake in the occipital cortex was 29.06% on the right and 37.88% on the left. This was compared to a group of 10 age-matched healthy controls (mean age 43.8 years; mean striatal BP% bilaterally 70.25, range 49.89 to 97.30) and to 9 age-matched patients with PD (mean age 44.8 years; mean striatal BP% 24.83, range 10.29 to 40.81). Tracer uptake was predominantly reduced in the posterior putamen, with a caudate/putamen ratio of 1.97 on the right and 1.30 on the left, corresponding to the typical pattern of neurodegeneration in PD (mean caudate/putamen ratio in the normal control group: 1.15, range 1.0 to 1.38; PD control group: 1.72, range 1.39 to 2.21; figure 2).

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1. 123I-FP-CIT SPECT: Axial brain images show caudate and putamen of the patient (A) and an age-matched normal control (B). Total striatal binding potential index: A: right 29.06%, left 37.88%; B: right 57.83%, left 62.40%.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 2. Radioactivity ratios for striatal subregions for the patient (filled circles), 9 age-matched patients with PD (gray boxes; mean ± 95% CI), and 10 age-matched normal controls (white boxes; mean ± 95% CI). Sbi = Striatal binding index = ratio of radioactivity counts between each striatal subregion and occipital cortex; PP = posterior putamen; AP = anterior putamen; CN = caudate nucleus; contralateral = hemisphere contralateral to clinically more affected side in PD and right hemisphere in normal controls.

At follow-up 3 months after the scan, very mild stiffness of the left hand as well as slight rest tremor and stiffness of the left leg were detected on neurologic examination. Treatment was started with the dual target of improving dystonia as well as parkinsonism, and a dopamine agonist (pramipexole, at a dosage of 1.4 mg/day) was chosen. This led to an improvement in the patient’s mild parkinsonian signs and symptoms and had a marked effect on his ability to exercise in that the amount of time he could exercise without cramps occurring increased to about 30 minutes.

Discussion.

This atypical presentation highlights the potential usefulness of dopamine transporter SPECT in the early diagnosis of PD. Cramping leg pain following physical exercise usually raises suspicion of arterial occlusive disease with intermittent hypoperfusion of a limb distal to an atherosclerotic stenosis or lumbar spinal canal stenosis with cauda equina compression. Lumbar canal stenosis with foot dystonia has also rarely been described.4 Other, rarer causes include exercise-induced hypocalcemic tetanic spasms in hypoparathyroidism.5 In dopa-responsive dystonia, where parkinsonism may also be present, diurnal fluctuation, a sustained buildup of dystonia as the day goes by, irrespective of the degree of physical exercise, is more characteristic.

The familial conditions paroxysmal kinesigenic dyskinesia (PKD) and paroxysmal nonkinesigenic dyskinesia (PNKD) differ from the pattern observed in our case. In PKD, very brief and frequent attacks are provoked by sudden movements, whereas in PNKD, external factors such as fatigue, alcohol, or caffeine provoke attacks that last from 10 minutes to several hours.

Paroxysmal exercise-induced dyskinesia is a rare familial condition with an autosomal dominant pattern of inheritance in most described families.6 Prolonged exercise is usually required to trigger an attack, and abnormal posturing takes 10 to 15 minutes to resolve.6 Symptomatic treatment options for paroxysmal exercise-induced dystonia are limited at present, although in rare cases, response to acetazolamide,6 carbamazepine, or l-dopa7 has been described.

The first cases of dystonia as the presenting feature of PD were described by Purves Stewart.1 In two out of three cases, foot dystonia was triggered by walking, and dystonia preceded other features of parkinsonism by up to 2 years. There have since been a few further reports of PD presenting with intermittent lower limb dystonia.8 One case2 resembling ours has been reported: in a 42-year-old marathon runner, prolonged running provoked disabling, unilateral foot dystonia, and the patient went on to develop typical parkinsonism a year later. Intervals of months to 13 years have been described between onset of dystonia and the emergence of other signs of parkinsonism.9 Dystonia at onset appears to be more frequent in parkin-positive patients.10

Treatment with l-dopa has been reported to lead to a deterioration of the dystonia in at least some cases,9 whereas dopamine agonists or anticholinergics can abolish it.8 Despite the absence of any treatment that can slow disease progression in PD, early diagnosis is important to instill confidence, avoid further inappropriate medical referrals, and advise on prognosis and subsequent symptomatic therapy.

Our case shows that in a case of intermittent exercise-induced focal cramps, the possibility of an atypical presentation of PD should be kept in mind. In the absence of the cardinal physical signs of PD, detection of dopaminergic neurodegeneration by dopamine transporter SPECT would provide support for dopamine replacement therapy.

  • Received May 13, 2002.
  • Accepted August 19, 2002.

References

  1. ↵
    Purves Stewart J. Paralysis agitans with an account of a new symptom. Lancet . 1898; 2: 1258–1260.
    OpenUrl
  2. ↵
    Lees AJ, Hardie RJ, Stern GM. Kinesigenic foot dystonia as a presenting feature of Parkinson’s disease. J Neurol Neurosurg Psychiatry . 1984; 47: 885.
    OpenUrl
  3. ↵
    Booij J, Habraken JBA, Bergmans P, et al. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson’s disease. J Nucl Med . 1998; 39: 1879–1884.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Blunt SB, Richards PG, Khalil N. Foot dystonia and lumbar canal stenosis. Mov Disord . 1996; 11: 723–725.
    OpenUrlPubMed
  5. ↵
    McCrory P. An unusual cause of gait disturbance in an elite sprinter. Mov Disord . 2000; 15: 176–177.
    OpenUrlPubMed
  6. ↵
    Bhatia KP, Soland VL, Bhatt MH, Quinn NP, Marsden CD. Paroxysmal exercise induced dystonia: eight new sporadic cases and a review of the literature. Mov Disord . 1997; 12: 1007–1012.
    OpenUrlCrossRefPubMed
  7. ↵
    Demirkian M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol . 1995; 38: 571–579.
    OpenUrlCrossRefPubMed
  8. ↵
    Poewe WH, Lees AJ. The pharmacology of foot dystonia in parkinsonism. Clin Neuropharmacol . 1987; 10: 47–56.
    OpenUrlPubMed
  9. ↵
    LeWitt PA, Burns RS, Newman RP. Dystonia in untreated parkinsonism. Clin Neuropharmacol . 1986; 9: 293–297.
    OpenUrlPubMed
  10. ↵
    Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature . 1998; 392: 605–608.
    OpenUrlCrossRefPubMed

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Case report.
    • Discussion.
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy

Dr. Jeffrey Allen and Dr. Nicholas Purcell

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • Dystonia
  • Parkinson's disease/Parkinsonism
  • SPECT

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Articles
    Paroxysmal dyskinesias in patients with HIV infection
    S.M. Mirsattari, M.E. Roke Berry, J.K. Holden et al.
    Neurology, January 01, 1999
  • Article
    The scientific and clinical basis for the treatment of Parkinson disease (2009)
    C. Warren Olanow, Matthew B. Stern, Kapil Sethi et al.
    Neurology, May 26, 2009
  • Articles
    Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia
    Y. Furukawa, T.G. Nygaard, M. Gütlich et al.
    Neurology, September 01, 1999
  • Articles
    Genotype–phenotype correlation of paroxysmal nonkinesigenic dyskinesia
    M. K. Bruno, H.-Y Lee, G.W.J. Auburger et al.
    Neurology, May 21, 2007
Neurology: 100 (12)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise